Home � News From SWITZERLAND � News From Healthcare and Medical
Switzerland : In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million in SWITZERLAND
| TI Ref No: | 503329031 |
| Date : | 26 Apr 2024 |
| Description: | Switzerland : In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million, SWITZERLAND |
| Document Type | Procurement News |
|
Click Here For Login If you are registered member, kindly login to view full details of this tender notice. |
|
|
Subscribe Now If you are not a subscriber, kindly contact nikhil.j@tendersinfo.com OR Naorm@export.gov.il |